全文获取类型
收费全文 | 1071篇 |
免费 | 97篇 |
国内免费 | 1篇 |
专业分类
电工技术 | 6篇 |
综合类 | 3篇 |
化学工业 | 531篇 |
金属工艺 | 7篇 |
机械仪表 | 20篇 |
建筑科学 | 29篇 |
能源动力 | 28篇 |
轻工业 | 149篇 |
水利工程 | 3篇 |
石油天然气 | 1篇 |
无线电 | 80篇 |
一般工业技术 | 179篇 |
冶金工业 | 40篇 |
原子能技术 | 1篇 |
自动化技术 | 92篇 |
出版年
2024年 | 2篇 |
2023年 | 10篇 |
2022年 | 124篇 |
2021年 | 178篇 |
2020年 | 38篇 |
2019年 | 36篇 |
2018年 | 49篇 |
2017年 | 29篇 |
2016年 | 55篇 |
2015年 | 40篇 |
2014年 | 52篇 |
2013年 | 75篇 |
2012年 | 57篇 |
2011年 | 89篇 |
2010年 | 49篇 |
2009年 | 42篇 |
2008年 | 37篇 |
2007年 | 33篇 |
2006年 | 30篇 |
2005年 | 28篇 |
2004年 | 20篇 |
2003年 | 13篇 |
2002年 | 11篇 |
2001年 | 8篇 |
2000年 | 3篇 |
1999年 | 11篇 |
1998年 | 7篇 |
1997年 | 5篇 |
1996年 | 7篇 |
1995年 | 6篇 |
1994年 | 4篇 |
1993年 | 2篇 |
1992年 | 1篇 |
1991年 | 3篇 |
1990年 | 2篇 |
1989年 | 3篇 |
1988年 | 1篇 |
1986年 | 2篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1983年 | 1篇 |
1981年 | 1篇 |
1976年 | 2篇 |
1969年 | 1篇 |
排序方式: 共有1169条查询结果,搜索用时 15 毫秒
941.
ABSTRACT This work investigates the relationship between proxies of innovation activities, such as patents and trademarks, and firm performance in terms of revenues, growth, and profitability. By resorting to the virtual universe of Italian manufacturing and service firms, this work provides a rather complete picture of the Intellectual Property (IP) strategies pursued by Italian firms, in terms of patents and trademarks, and studies whether the two instruments for protecting IP exhibit complementarity or substitutability. In addition, and to our knowledge novel, we propose a measure of concordance (or proximity) between the patents and trademarks owned by the same firm and we then investigate whether such concordance exerts any effect on performance. The results suggest that while patents and trademarks independently exert a relevant impact on firm performance, there is no convincing evidence in favour of a complementary role of IP. 相似文献
942.
Bonetto Sabrina Colombero Chiara Comina Cesare Giordano Nicolò Giuliani Andrea Mandrone Giuseppe Nicola Simone Tible Paolo 《Bulletin of Engineering Geology and the Environment》2018,77(2):541-553
Bulletin of Engineering Geology and the Environment - A case study on the use of direct and indirect investigations for the effectiveness evaluation of jet-grouting interventions for bridge scour... 相似文献
943.
Angela Serena Maione Ilaria Stadiotti Chiara Assunta Pilato Gianluca Lorenzo Perrucci Valentina Saverio Valentina Catto Giulia Vettor Michela Casella Anna Guarino Gianluca Polvani Giulio Pompilio Elena Sommariva 《International journal of molecular sciences》2021,22(5)
Arrhythmogenic Cardiomyopathy (ACM) is characterized by the replacement of the myocardium with fibrotic or fibro-fatty tissue and inflammatory infiltrates in the heart. To date, while ACM adipogenesis is a well-investigated differentiation program, ACM-related fibrosis remains a scientific gap of knowledge. In this study, we analyze the fibrotic process occurring during ACM pathogenesis focusing on the role of cardiac mesenchymal stromal cells (C-MSC) as a source of myofibroblasts. We performed the ex vivo studies on plasma and right ventricular endomyocardial bioptic samples collected from ACM patients and healthy control donors (HC). In vitro studies were performed on C-MSC isolated from endomyocardial biopsies of both groups. Our results revealed that circulating TGF-β1 levels are significantly higher in the ACM cohort than in HC. Accordingly, fibrotic markers are increased in ACM patient-derived cardiac biopsies compared to HC ones. This difference is not evident in isolated C-MSC. Nevertheless, ACM C-MSC are more responsive than HC ones to TGF-β1 treatment, in terms of pro-fibrotic differentiation and higher activation of the SMAD2/3 signaling pathway. These results provide the novel evidence that C-MSC are a source of myofibroblasts and participate in ACM fibrotic remodeling, being highly responsive to ACM-characteristic excess TGF-β1. 相似文献
944.
945.
Eva Schaller Andi Ma Lisa Chiara Gosch Adrian Klefenz David Schaller Nils Goehringer Leonard Kaps Detlef Schuppan Andrea Volkamer Rainer Schobert Bernhard Biersack Bianca Nitzsche Michael Hpfner 《International journal of molecular sciences》2021,22(5)
New 2-(thien-2-yl)-acrylonitriles with putative kinase inhibitory activity were prepared and tested for their antineoplastic efficacy in hepatoma models. Four out of the 14 derivatives were shown to inhibit hepatoma cell proliferation at (sub-)micromolar concentrations with IC50 values below that of the clinically relevant multikinase inhibitor sorafenib, which served as a reference. Colony formation assays as well as primary in vivo examinations of hepatoma tumors grown on the chorioallantoic membrane of fertilized chicken eggs (CAM assay) confirmed the excellent antineoplastic efficacy of the new derivatives. Their mode of action included an induction of apoptotic capsase-3 activity, while no contribution of unspecific cytotoxic effects was observed in LDH-release measurements. Kinase profiling of cancer relevant protein kinases identified the two 3-aryl-2-(thien-2-yl)acrylonitrile derivatives 1b and 1c as (multi-)kinase inhibitors with a preferential activity against the VEGFR-2 tyrosine kinase. Additional bioinformatic analysis of the VEGFR-2 binding modes by docking and molecular dynamics calculations supported the experimental findings and indicated that the hydroxy group of 1c might be crucial for its distinct inhibitory potency against VEGFR-2. Forthcoming studies will further unveil the underlying mode of action of the promising new derivatives as well as their suitability as an urgently needed novel approach in HCC treatment. 相似文献
946.
Francesco Finamore Antonella Cecchettini Elisa Ceccherini Giovanni Signore Francesco Ferro Silvia Rocchiccioli Chiara Baldini 《International journal of molecular sciences》2021,22(9)
Primary Sjögren’s syndrome (pSS) is a complex heterogeneous disease characterized by a wide spectrum of glandular and extra-glandular manifestations. In this pilot study, a SWATH-MS approach was used to monitor extracellular vesicles-enriched saliva (EVs) sub-proteome in pSS patients, to compare it with whole saliva (WS) proteome, and assess differential expressed proteins between pSS and healthy control EVs samples. Comparison between EVs and WS led to the characterization of compartment-specific proteins with a moderate degree of overlap. A total of 290 proteins were identified and quantified in EVs from healthy and pSS patients. Among those, 121 proteins were found to be differentially expressed in pSS, 82% were found to be upregulated, and 18% downregulated in pSS samples. The most representative functional pathways associated to the protein networks were related to immune-innate response, including several members of S100 protein family, annexin A2, resistin, serpin peptidase inhibitors, azurocidin, and CD14 monocyte differentiation antigen. Our results highlight the usefulness of EVs for the discovery of novel salivary-omic biomarkers and open novel perspectives in pSS for the identification of proteins of clinical relevance that could be used not only for the disease diagnosis but also to improve patients’ stratification and treatment-monitoring. Data are available via ProteomeXchange with identifier PXD025649. 相似文献
947.
Sara Elena Rebuzzi Lodovica Zullo Giovanni Rossi Massimiliano Grassi Veronica Murianni Marco Tagliamento Arsela Prelaj Simona Coco Luca Longo Maria Giovanna Dal Bello Angela Alama Chiara Dellepiane Elisa Bennicelli Umberto Malapelle Carlo Genova 《International journal of molecular sciences》2021,22(5)
In the scenario of systemic treatment for advanced non-small cell lung cancer (NSCLC) patients, one of the most relevant breakthroughs is represented by targeted therapies. Throughout the last years, inhibitors of the epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), c-Ros oncogene 1 (ROS1), and V-raf murine sarcoma viral oncogene homolog B (BRAF) have been approved and are currently used in clinical practice. However, other promising molecular drivers are rapidly emerging as therapeutic targets. This review aims to cover the molecular alterations with a potential clinical impact in NSCLC, including amplifications or mutations of the mesenchymal–epithelial transition factor (MET), fusions of rearranged during transfection (RET), rearrangements of the neurotrophic tyrosine kinase (NTRK) genes, mutations of the Kirsten rat sarcoma viral oncogene (KRAS) and phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha (PIK3CA), as well as amplifications or mutations of human epidermal growth factor receptor 2 (HER2). Additionally, we summarized the current status of targeted agents under investigation for such alterations. This revision of the current literature on emerging molecular targets is needed as the evolving knowledge on novel actionable oncogenic drivers and targeted agents is expected to increase the proportion of patients who will benefit from tailored therapeutic approaches. 相似文献
948.
Antonino Tuttolomondo Maria Grazia Puleo Maria Chiara Velardo Francesca Corpora Mario Daidone Antonio Pinto 《International journal of molecular sciences》2020,21(24)
Among the causes of global death and disability, ischemic stroke (also known as cerebral ischemia) plays a pivotal role, by determining the highest number of worldwide mortality, behind cardiomyopathies, affecting 30 million people. The etiopathogenetic burden of a cerebrovascular accident could be brain ischemia (~80%) or intracranial hemorrhage (~20%). The most common site when ischemia occurs is the one is perfused by middle cerebral arteries. Worse prognosis and disablement consequent to brain damage occur in elderly patients or affected by neurological impairment, hypertension, dyslipidemia, and diabetes. Since, in the coming years, estimates predict an exponential increase of people who have diabetes, the disease mentioned above constitutes together with stroke a severe social and economic burden. In diabetic patients after an ischemic stroke, an exorbitant activation of inflammatory molecular pathways and ongoing inflammation is responsible for more severe brain injury and impairment, promoting the advancement of ischemic stroke and diabetes. Considering that the ominous prognosis of ischemic brain damage could by partially clarified by way of already known risk factors the auspice would be modifying poor outcome in the post-stroke phase detecting novel biomolecules associated with poor prognosis and targeting them for revolutionary therapeutic strategies. 相似文献
949.